A1AAK

muvalaplin

Created:2023-12-15
Last modified:  2024-05-08

Find related ligands:

Chemical Details

Formal Charge0
Atom Count106
Chiral Atom Count6
Bond Count111
Aromatic Bond Count18
2D diagram of A1AAK

Chemical Component Summary

Namemuvalaplin
Synonyms(2S,2'S,2''S)-3,3',3''-[azaniumyltris(methylene-3,1-phenylene)]tris{2-[(3R)-pyrrolidin-1-ium-3-yl]propanoate}
Systematic Name (OpenEye OEToolkits)(2~{S})-3-[3-[[bis[[3-[(2~{S})-3-oxidanyl-3-oxidanylidene-2-[(3~{R})-pyrrolidin-3-yl]propyl]phenyl]methyl]amino]methyl]phenyl]-2-[(3~{R})-pyrrolidin-3-yl]propanoic acid
FormulaC42 H54 N4 O6
Molecular Weight710.901
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESACDLabs12.01O=C(O)C(Cc1cccc(c1)CN(Cc1cccc(CC(C(=O)O)C2CCNC2)c1)Cc1cc(CC(C2CCNC2)C(=O)O)ccc1)C1CCNC1
SMILESCACTVS3.385OC(=O)[CH](Cc1cccc(CN(Cc2cccc(C[CH]([CH]3CCNC3)C(O)=O)c2)Cc4cccc(C[CH]([CH]5CCNC5)C(O)=O)c4)c1)[CH]6CCNC6
SMILESOpenEye OEToolkits2.0.7c1cc(cc(c1)CN(Cc2cccc(c2)CC(C3CCNC3)C(=O)O)Cc4cccc(c4)CC(C5CCNC5)C(=O)O)CC(C6CCNC6)C(=O)O
Canonical SMILESCACTVS3.385 OC(=O)[C@@H](Cc1cccc(CN(Cc2cccc(C[C@@H]([C@H]3CCNC3)C(O)=O)c2)Cc4cccc(C[C@@H]([C@H]5CCNC5)C(O)=O)c4)c1)[C@H]6CCNC6
Canonical SMILESOpenEye OEToolkits2.0.7 c1cc(cc(c1)CN(Cc2cccc(c2)C[C@@H]([C@H]3CCNC3)C(=O)O)Cc4cccc(c4)C[C@@H]([C@H]5CCNC5)C(=O)O)C[C@@H]([C@H]6CCNC6)C(=O)O
InChIInChI1.06 InChI=1S/C42H54N4O6/c47-40(48)37(34-10-13-43-22-34)19-28-4-1-7-31(16-28)25-46(26-32-8-2-5-29(17-32)20-38(41(49)50)35-11-14-44-23-35)27-33-9-3-6-30(18-33)21-39(42(51)52)36-12-15-45-24-36/h1-9,16-18,34-39,43-45H,10-15,19-27H2,(H,47,48)(H,49,50)(H,51,52)/t34-,35-,36-,37-,38-,39-/m0/s1
InChIKeyInChI1.06 BRLGERLDHZRETI-BGBFCPIGSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
DrugBank IDDB21568 
NameMuvalaplin
Groups investigational
DescriptionMuvalaplin is a small molecule drug. Muvalaplin is under investigation in clinical trial NCT05563246 (A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events). Muvalaplin has a monoisotopic molecular weight of 710.4 Da.
SynonymsMuvalaplin
CAS number2565656-70-2

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
NameTarget SequencePharmacological ActionActions
Apolipoprotein(a)MEHKEVVLLLLLFLKSAAPEQSHVVQDCYHGDGQSYRGTYSTTVTGRTCQ...unknowninhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 155369486
ChEMBL CHEMBL4802585